Treatment of patients with erosive esophagitis. A modern view on the problem

Treatment of patients with erosive esophagitis. A modern view on the problem

Gastroesophageal reflux disease is one of the most common diseases of the gastroenterological profile. There are several forms of illness, including non-erosive forms, erosive esophagitis, Barrett esophagus. The article provides an overview of the drugs used to treat the erosive form of GERD and lon...

Full description

Bibliographic Details
Main Authors:	S. V. Morozov, Yu. A. Kucheryavy, V. S. Kropochev
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2018-04-01
Series:	Медицинский совет
Subjects:	gastroesophageal reflux disease treatment erosive esophagitis proton pump inhibitors dexlansoprazole
Online Access:	https://www.med-sovet.pro/jour/article/view/2381

Similar Items

Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
by: Mermelstein J, et al.
Published: (2016-07-01)

GASTROESOPHAGEAL REFLUX: NEW THERAPEUTIC PROSPECTS
by: S. S. Kardasheva, et al.
Published: (2017-07-01)

Increase in treatment compliance reveals new options of treatment of gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2024-03-01)

Assessment of effectiveness of different dosage regimens of pantoprazole in controlling symptoms and healing esophageal lesions of patients with mild erosive esophagitis
by: Luciana Dias MORETZSOHN, et al.
Published: (2002-04-01)

Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis
by: Jie He, et al.
Published: (2023-07-01)

Contemporary Approaches to the Treatment of Gastroesophageal Reflux Disease
by: Boris D. Starostin
Published: (2019-03-01)

Differentiated approach to the choice of PPI in a patient with GERD in the practice of an outpatient (with a clinical case)
by: I. G. Pakhomova, et al.
Published: (2021-01-01)

The Role of Proton Pump Inhibitors in the Management of Pediatric Eosinophilic Esophagitis
by: Carolina Gutiérrez-Junquera, et al.
Published: (2018-05-01)

The Effect of Esomeprazole 40 mg Single Therapy in Patients with Non-Erosive Reflux Disease Who Are Resistant to Standard-Dose Proton Pump Inhibitor Therapy: An Open-Label Multicenter Study
by: Jae Kyu Sung, et al.
Published: (2016-12-01)

Morphological Diagnosis of Erosive Esophagitis in Patients with Gastroesophageal Reflux Disease
by: Yu.A. Haidar, et al.
Published: (2016-02-01)

The Prevalence and Clinical Features of Non-responsive Gastroesophageal Reflux Disease to Practical Proton Pump Inhibitor Dose in Korea: A Multicenter Study
by: Hong Jun Park, et al.
Published: (2016-07-01)

Prevalence of laryngeal alterations in patients with erosive esophagitis
by: Coelho, Marina Serrato, et al.
Published: (2010-06-01)

Correlation Between Gastroesophageal Reflux Disease Questionnaire and Erosive Esophagitis in School-aged Children Receiving Endoscopy
by: Jhen-Yan Chiu, et al.
Published: (2014-12-01)

GASTRO-OESOPHAGEAL REFLUX DISEASE: WHAT IS KNOWN, WHERE DO WE GO?
by: Bogdan Ianoşi, et al.
Published: (2018-03-01)

Longitudinal study of gastroesophageal reflux and erosive tooth wear
by: Clive H. Wilder-Smith, et al.
Published: (2017-10-01)

Practical Aspects of Pathogenetic Therapy for Gastroesophageal Reflux Disease
by: V.P. Shipulin
Published: (2015-02-01)

The Effect of Dexlansoprazole on Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis
by: Gabriel Pereira Nunes, et al.
Published: (2024-01-01)

Modern achievements in the diagnosis and treatment of the refractory gastroesophageal reflux disease
by: V T Ivashkin, et al.
Published: (2018-08-01)

Inadequate response to proton pump inhibitor therapy: Causes and patient management tactics
by: Iu V Evsiutina, et al.
Published: (2015-02-01)

Effect of Proton Pump Inhibitors in Bronchiectatic Patients with Gastroesophageal Reflux Disease
by: Byungkyu Ahn, et al.
Published: (2016-07-01)

Efficacy of the four weeks treatment of omeprazole plus mosapride combination therapy compared with that of omeprazole monotherapy in patients with proton pump inhibitor-refractory gastroesophageal reflux disease: a randomized controlled trial
by: Sirinawasatien A, et al.
Published: (2019-07-01)

Gastroesophageal reflux disease: exaggerations, evidence and clinical practice
by: Cristina Targa Ferreira, et al.
Published: (2014-03-01)

Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study
by: Hyun Lim, et al.
Published: (2023-12-01)

Options for optimizing treatment of gastroesophageal reflux disease with proton pump inhibitors
by: M. F. Osipenko, et al.
Published: (2015-12-01)

Gastroesophageal Reflux Disease: diagnosis and treatment
by: Michał Zdybel, et al.
Published: (2023-05-01)

ESTIMATION OF CLINICAL AND PHARMACOECONOMIC EFFICIENCY OF PROTON PUMP INHIBITORS DURING GASTROESOPHAGEAL REFLUX DISEASE (GERD) TREATMENT
by: N. E. Shabanova, et al.
Published: (2018-12-01)

Treatment strategies for reflux esophagitis including a potassium‐competitive acid blocker: A cost‐effectiveness analysis in Japan
by: Yasuki Habu, et al.
Published: (2021-09-01)

Differences in Dietary and Lifestyle Triggers between Non-Erosive Reflux Disease and Reflux Esophagitis—A Multicenter Cross-Sectional Survey in China
by: Yang Chen, et al.
Published: (2023-07-01)

Proton pumps inhibitors in gastroesophageal reflux disease: what is the best regimen? A based evidence review
by: Rui JF Silva, et al.
Published: (2021-07-01)

Transoral Incisionless Fundoplication for Refractory Gastroesophageal Reflux Disease: Where Do We Stand?
by: Deepanshu Jain, et al.
Published: (2016-03-01)

Omeprazole Induced Increase in Liver Markers-A Case Report
by: Marwa F Elmahdy, et al.
Published: (2019-10-01)

Results of the study of conservative treatment of laryngeal manifestations of laryngopharyngeal reflux
by: I. B. Angotoeva, et al.
Published: (2021-12-01)

ACTUAL ASPECTS OF ANTI-SECRETOR THERAPY OF GASTROESOPHAGEAL REFLUX DISEASE
by: D. I. Trukhan, et al.
Published: (2017-11-01)

Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?
by: Reidar Fossmark, et al.
Published: (2023-09-01)

Randomized Controlled Trial Comparing the Efficacy of Sustained-Release Formula of Mosapride-Plus-Esomeprazole Combination Therapy to Esomeprazole Monotherapy in Patients with Gastroesophageal Reflux Disease
by: Hye Kyung Jeon, et al.
Published: (2022-04-01)

Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor
by: A. López-Colombo, et al.
Published: (2017-04-01)

Chronic Asthma and Gastro-Esophageal Reﬂux Disease: The Treatment Plans
by: Leila Ghofraniha, et al.
Published: (2015-09-01)

The Prevalence of Reflux Esophagitis in the Elderly and Its Associated Risk Factors
by: Cosmas Rinaldi A Lesmana, et al.
Published: (2016-09-01)

Distinct Microbiota Dysbiosis in Patients with Non-Erosive Reflux Disease and Esophageal Adenocarcinoma
by: Jerry Zhou, et al.
Published: (2020-07-01)

Comparative analysis of the effect of PO administered acid suppressants on gastric pH in healthy cats
by: Phillip Ryan, et al.
Published: (2020-09-01)